Altmetrics: What, Where, Why? by Catherine Chimes Head of Marketing & Customer Relations Altmetric LLP

Total Page:16

File Type:pdf, Size:1020Kb

Altmetrics: What, Where, Why? by Catherine Chimes Head of Marketing & Customer Relations Altmetric LLP ARTICLE Altmetrics ARTICLE Altmetrics: What, Where, Why? By Catherine Chimes Head of Marketing & Customer Relations Altmetric LLP Altmetrics have become a buzzword in scholarly altmetrics data add a new layer of insight into the publishing in the last year. But just what is all the attention and societal impact the work has gar- fuss about? nered. As evaluation criteria expand and budgets tight- By providing both qualitative and quantitative en, authors, publishers, universities, and research data for a paper, altmetrics can help authors and bodies are increasingly looking for additional ways publishers explore, understand, and engage in to demonstrate the reach and value of their work. the conversations that are going on around the Traditional measures of scholarly impact, such as research. This can be used to help influence fu- the Impact Factor, tend to focus only at the jour- ture publications or research, and serves to further nal level—with little insight into how the individ- stimulate the academic discussion. ual articles within a publication perform. Recent advancements have therefore seen new measures emerge, which take a more granular view of the dissemination of articles and associ- ated research content. Commonly referred to as The task of tracking and reporting on an indi- altmetrics, or alternative metrics, these new forms vidual scholarly article is not without obstacles— of measurement look beyond citation and pub- not least the need to disambiguate between differ- lisher usage counts, with a focus on online “men- ent versions of a single piece of work. In order to tions” of a research work. By collating data from do this with accuracy, at Altmetric, data collation sources, such as social media, blogs, news outlets, is based on a scholarly identifier unique to each bookmarking sites, peer-review forums, and policy article—for example, the DOI or PubMed ID, documents, we are now able to see a much richer will remain the same whether hosted on the pub- picture of the true reach of the scholarly content. lisher’s site or within an institutional repository. Numerous tools developed by a handful of Using this method, we have so far collated over small start-up companies, such as Altmetric, Im- 7.5 million mentions, relating to over 1.8 million pact Story, and Plum Analytics, are now available articles. for easily tracking and monitoring these channels, Some papers, of course, will receive much more which are becoming increasingly important in the attention than others. It is important to remember wider scholarly context. As a way of determin- that altmetrics provide an indication of reach, not ing reach beyond (but complementary to) the quality. An article or topic that has broad appeal, more traditional journal-level citation tracking, particularly amongst the general public, is likely to 10 Editorial Ofce News www.ismte.org FEBRUARY 2014 ARTICLE Altmetrics ARTICLE see a high number of mentions. Examples of this to begin to achieve a consensus on the standard- include the 2013 papers, “Overview of Active Ce- ization for altmetrics data as a whole, and to dis- sium Contamination of Freshwater Fish in Fukushima cuss and form a roadmap for how the field is likely and Eastern Japan,” which has received over 9,000 to progress. mentions on Twitter alone, and “Primary Preven- 2013 saw a number of prominent titles move to tion of Cardiovascular Disease with a Mediterra- integrate altmetrics data on their journal platforms nean Diet,” which has so far been featured by over using the Altmetric application programming in- 40 mainstream news outlets. terface (API). Publishers including Nature Pub- The scope for development within altmetrics is lishing Group, the BMJ Group, the Royal Society huge. To their favour, altmetrics provide a rapid of Chemistry, and BioMed Central all now display and timely method of assessing the attention a pa- altmetrics for each article—usually accessible via per receives—particularly in comparison to cita- a “metrics” tab or similar. The team at Nature tions, which take years to accumulate. By examin- Climate Change is currently trialing a “trending ing the raw data behind each mention, it is often articles” list, based on the online activity on any possible to identify online communities who have given day. The data are pulled on request directly taken an interest in the research but may other- from our servers, and provide users with an in- wise have gone undetected. This is particularly stant compilation of the mentions for each paper. relevant in cases where the work has a more prac- Displaying the data in this way allows authors and tical application—for example a paper which is readers to easily gauge the attention their work is little cited may in fact have had a large amount of receiving, and can help the publishing teams iden- impact on policy and amongst the clinical nursing tify which are their most talked-about articles, or community, who do not tend to actively publish where there is perhaps a need to increase their research. communication efforts. One must consider that the measures used to- Additionally, we offer the opportunity to ex- day may not be considered important in five years’ plore the altmetrics data for any article via a time, and there are some contentious issues in the web application: the Altmetric Explorer. Users space that must be continually addressed. At pres- can search by DOI, keyword, journal, publisher, ent, the collation of altmetrics is not standardized, funder, and a number of other filters. This enables although there is much crossover between provid- a comparison between related journals, which can ers and sources. It is yet to be determined which give a unique insight into how your publication is outlets are the most important to track—and the performing. results need to be carefully reviewed in context Overall, the reception for altmetrics has so far before any meaningful conclusions can be drawn. been mostly positive. Uptake amongst publish- Technical limitations, such as the inability to track ers has been high, and already we see examples multimedia (audio and video) unless the unique of researchers incorporating the data surrounding identifier can be found in the metadata, are a rec- their articles into their CVs. As the amount of on- ognized issue. Others have raised concerns that line discussion around published research contin- the altmetrics data could be easily gamed—fake ues to grow, altmetrics as a tool for identifying and Twitter accounts abound, and large numbers of exploring the broader impact of scholarly work are mentions are simple to create. At Altmetric we anticipated to continue to gain in significance. have developed a spam-watching algorithm in If you are interested in finding out more or in- order to combat this—any suspect mentions are tegrating altmetrics data for your journal, you can flagged and investigated by our team. visit www.altmetric.com, or email info@altmetric. Recent workshops run by the Public Library com. We’re always open to new opportunities and of Science (PLOS) and the National Information would be happy to work with you to develop a Standards Organisation (NISO) have taken steps custom solution. FEBRUARY 2014 Editorial Ofce News www.ismte.org 11.
Recommended publications
  • Stephen P. Lock on "Journalology"
    INSTITUTE FOn SCIENTl FICl NF0F4MAT10N8 3501 MARKET ST PHILADELPHIA PA 19104 Stephen P. Lock on “Journalology” Number 3 January 15, 1990 I don’t remember exactly how long I have Lock: Editor and Scholar known Stephen P. Lock. Our first encounter was probably at a meeting of the Council of Biology Editors (CBE) some 20 years Stephen P. Lock was born in 1929 and re- ago. It is somewhat unsettling to realize that ceived his education at Queen’s College, so much time has gone by. Equally disquiet- Cambridge University, UK, and the Medical ing is the notion that Steve will soon retire College of St. Bartholomew’s Hospital. as editor of the venerable British Medical Trained as a hematologist, he served on the Journal (BMJ). But in the near future Steve staffs of various London teaching hospitals, will indeed step down, having helped train including St. Bartholomew’s and the Hos- his successor, due to be appointed in the fall pital for Sick Children, before being ap- of 1990. pointed assistant editor of BMJ in 1964. It seems odd to refer to Lock as an elder After serving as senior assistant editor and statesman of biomedical editing-however deputy editor, Lock became editor in 1975. accurate that description might be. The word I am amused that Steve opened his talk that comes to mind when I think of Steve with the traditional, mythical reminder about is youth. This youthfidness is reflected in the estimates of the number of extant jour- his writing and in his approach to problems. nals.
    [Show full text]
  • Defining Covid-19 Elimination
    EDITORIALS Department of Preventive and Social BMJ: first published as 10.1136/bmj.n1794 on 15 July 2021. Downloaded from Medicine, University of Otago, Dunedin, Defining covid-19 elimination New Zealand Correspondence to: D C G Skegg Elimination is achievable and should not be confused with eradication [email protected] Cite this as: BMJ 2021;374:n1794 David CG Skegg, Philip C Hill http://dx.doi.org/10.1136/bmj.n1794 Speaking about progress towards ending the covid-19 “zero covid” for a prolonged period. Even with border Published: 15 July 2021 epidemic in the United States, Anthony Fauci said: restrictions and strict quarantine, incursions of the “We will end the epidemic phase, and we will likely virus occur from time to time, leading to clusters of get somewhere between control and elimination, infections and occasional large outbreaks. In the more likely closer to control.”1 Now authorities in Australian state of Victoria, for example, a resurgence England are abandoning most efforts to control, let of covid-19 last year peaked at over 700 cases a day, alone eliminate, the infection.2 Throughout the before being extinguished after three months.11 pandemic, the word “elimination” has been used in Despite such setbacks, Australia and New Zealand different senses. Many confuse elimination with remain healthy economies with largely normal eradication, which normally means permanent community life, apart from temporary border reduction to zero of the worldwide incidence of an restrictions. Both are developing plans for a phased infection—as was achieved for smallpox.3 This reopening of borders. confusion helps to make the idea of eliminating The likely consequences of not aiming for elimination covid-19 seem impossible and not worth pursuing.
    [Show full text]
  • Open Access Policies of Leading Medical Journals: a Cross-Sectional Study
    Open access Research BMJ Open: first published as 10.1136/bmjopen-2018-028655 on 20 June 2019. Downloaded from Open access policies of leading medical journals: a cross-sectional study Tim S Ellison, 1 Tim Koder, 2 Laura Schmidt, 2 Amy Williams, 1 Christopher C Winchester 2 To cite: Ellison TS, Koder T, ABSTRACT Strengths and limitations of this study Schmidt L, et al. Open Objectives Academical and not-for-profit research access policies of leading funders are increasingly requiring that the research they ► This manuscript includes a cross-sectional analysis medical journals: a cross- fund must be published open access, with some insisting sectional study. BMJ Open of open access policies of medical journals with a on publishing with a Creative Commons Attribution (CC 2019;9:e028655. doi:10.1136/ high impact factor, including society-owned jour- BY) licence to allow the broadest possible use. We aimed bmjopen-2018-028655 nals, from multiple publishers. to clarify the open access variants provided by leading ► The open access policies of all journals analysed ► Prepublication history medical journals and record the availability of the CC BY were clarified, and confirmation of our findings and additional material for licence for commercially funded research. was received by email from 97% of the contacted this paper are available Methods We identified medical journals with a 2015 online. To view these files, journals. impact factor of ≥15.0 on 24 May 2017, then excluded please visit the journal online ► Open access policies of the journals and publishers from the analysis journals that only publish review articles.
    [Show full text]
  • The Journal Impact Factor Denominator Defining Citable (Counted) Items
    COMMENTARIES The Journal Impact Factor Denominator Defining Citable (Counted) Items Marie E. McVeigh, MS The items counted in the denominator of the impact fac- tor are identifiable in the Web of Science database by hav- Stephen J. Mann ing the index field document type set as “Article,” “Re- view,” or “Proceedings Paper” (a specialized subset of the VER ITS 30-YEAR HISTORY, THE JOURNAL IMPACT article document type). These document types identify the factor has been the subject of much discussion scholarly contribution of the journal to the literature and and debate.1 From its first release in 1975, bib- are counted as “citable items” in the denominator of the im- liometricians and library scientists discussed its pact factor. A journal accepted for coverage in the Thom- Ovalue and its vagaries. In the last decade, discussion has 6 son Reuters citation database is reviewed by experts who shifted to the way in which impact factor data are used. In consider the bibliographic and bibliometric characteristics an environment eager for objective measures of productiv- of all article types published by that journal (eg, items), which ity, relevance, and research value, the impact factor has been are covered by that journal in the context of other materi- applied broadly and indiscriminately.2,3 The impact factor als in the journal, the subject, and the database as a whole. has gone from being a measure of a journal’s citation influ- This journal-specific analysis identifies the journal sec- ence in the broader literature to a surrogate that assesses tions, subsections, or both that contain materials likely to the scholarly value of work published in that journal.
    [Show full text]
  • Core Competencies for Scientific Editors Of
    Moher et al. BMC Medicine (2017) 15:167 DOI 10.1186/s12916-017-0927-0 CORRESPONDENCE Open Access Core competencies for scientific editors of biomedical journals: consensus statement David Moher1,2* , James Galipeau3, Sabina Alam4, Virginia Barbour5, Kidist Bartolomeos6, Patricia Baskin7,8, Sally Bell-Syer9,10, Kelly D. Cobey1,2,11, Leighton Chan12, Jocalyn Clark13, Jonathan Deeks14, Annette Flanagin15, Paul Garner16, Anne-Marie Glenny17, Trish Groves18, Kurinchi Gurusamy19, Farrokh Habibzadeh20,21,22, Stefanie Jewell-Thomas23, Diane Kelsall24, José Florencio Lapeña Jr22,25,26,27, Harriet MacLehose28, Ana Marusic29,30, Joanne E. McKenzie31, Jay Shah32,33,34, Larissa Shamseer1,2, Sharon Straus35, Peter Tugwell2,36,37, Elizabeth Wager38,39, Margaret Winker22 and Getu Zhaori40 Abstract Background: Scientific editors are responsible for deciding which articles to publish in their journals. However, we have not found documentation of their required knowledge, skills, and characteristics, or the existence of any formal core competencies for this role. Methods: We describe the development of a minimum set of core competencies for scientific editors of biomedical journals. Results: The 14 key core competencies are divided into three major areas, and each competency has a list of associated elements or descriptions of more specific knowledge, skills, and characteristics that contribute to its fulfillment. Conclusions: We believe that these core competencies are a baseline of the knowledge, skills, and characteristics needed to perform competently the duties of a scientific editor at a biomedical journal. Keywords: Core competencies, Scientific editor, Biomedical journal, Delphi, Expert consensus, Editor role Introduction and in guidance for members of editor organizations Scientific editors (editors are responsible for the content [3–8].
    [Show full text]
  • Scientific Data
    Author: Amye Kenall, Associate Publisher, BioMed Central *For internal use only Open Data Research data: from journal policy to practice “[O]pen access to raw data will go the same way as open access to published papers…It would not be a surprise if, in a decade’s time, funders finally get tired of paying for data that researchers keep As part of a SpringerNature-wide project, we aim to provide consistent data policies and services to every journal. to themselves…we should fully expect funders to demand that grantees share data” Why? y At least 28 research funders globally have policies or mandates Andrew J Vickers, Memorial Sloan Kettering Cancer Center y Improving author service by standardizing research www.bmj.com/content/342/bmj.d2323 (2011) that require data archiving as a condition of grants, including: data policies and procedures and increasing the y National Science Foundation (NSF) visibility and connectivity of their articles and data y National Institutes of Health (NIH) y Improving editor and peer reviewer service with What do we plan to provide and when? y Wellcome Trust better guidelines and support for data policies, and visibility of data in the peer-review process y A research data policy for every relevant publication (journals, books, proceedings) y Bill and Melinda Gates Foundation y Improving reader service with more consistent y Begin by developing 4 standardized data policies y Sharing data is good for research—and researchers and useful links to data y First groups of journals to introduce standard policy in
    [Show full text]
  • ACADEMIC 1 Improving Healthcare Outcomes
    Sharing knowledge and expertise ACADEMIC 1 Improving healthcare outcomes Sharing the newest ideas, opinions and data Supporting health professionals’ learning and development Developing tools to make information accessible and useful Using digital technology to make best evidence instantly available That’s what BMJ does. We’ve been doing it since 1840. 2 A healthier world Since starting out as the publisher of a single “We have a clear vision of ‘A Healthier World’ medical journal in 1840, we have developed a and use our values to inform the decisions unique range of capabilities to meet the needs professionals, institutions and organisations. we take to help achieve that vision. The voice of our customers is vitally • Leading source of medical information for over important to us - we listen and respond 170 years to their needs, ensuring we provide high- • The BMJ is the fourth most cited general quality evidence based products for medical journal in the world healthcare professionals, their institutions, • Each month, more than five million users visit organisations and governments.” our websites, where we have content available in 11 languages • Over 700,000 healthcare professionals from Peter Ashman more than 100 countries access our revision CEO, BMJ resources and online learning tools [email protected] bmj.com/company 3 Global healthcare knowledge provider BMJ shares knowledge and expertise to improve experiences, outcomes and value. From specialist publications and decision support to online learning, our products and services help improve the educational development of students and professionals. They also help organisations improve their research and development services. Alert Drive research to publication Receive customisable emails containing Help improve research outputs and interest-related content.
    [Show full text]
  • Journals from BMJ
    Journals from BMJ journals.bmj.com BMJ started out over 170 years ago as Providing high quality content for health professionals and a medical journal, publishing our first researchers across the world. Our journals include not only the BMJ, research paper. but some of the most influential speciality journals in their field. Now, as a global brand with a worldwide audience, we help medical organisations and clinicians tackle today’s most critical • In the last 12 months, over 50 million unique users accessed healthcare challenges. our subscription journals online, generating over 107 million page views. What is an Our vision is to create ‘a healthier world’. • Nearly 80% of our titles saw Impact Factor rises in 2014. Impact Factor? BMJ’s journals division now publishes more than 50 of the • 21% of our users view journal content from mobile devices. An Impact Factor (IF) is a measure of world’s leading medical and allied science journals. In doing so, the frequency with which the average we have pioneered the migration to digital publishing and the article in a journal has been cited in development of open access. a particular year. The annual Journal For more information or to of Citation Reports impact factor is a ratio between citations and recent Today, our expertise extends to medical education, clinical arrange a trial, please contact: citable items published. Thus, the decision support, data analytics and quality improvement to BMJ Consortia sales impact factor of a journal is calculated enhance day to day decision-making and healthcare delivery. by dividing the number of current E: [email protected] year citations to the source items T: +44 (0) 20 7383 6438 published in that journal during the “At BMJ we believe the work we do previous two years.
    [Show full text]
  • SPRINGER NATURE Products, Services & Solutions 2 Springer Nature Products, Services & Solutions Springernature.Com
    springernature.com Illustration inspired by the work of Marie Curie SPRINGER NATURE Products, Services & Solutions 2 Springer Nature Products, Services & Solutions springernature.com About Springer Nature Springer Nature advances discovery by publishing robust and insightful research, supporting the development of new areas of knowledge, making ideas and information accessible around the world, and leading the way on open access. Our journals, eBooks, databases and solutions make sure that researchers, students, teachers and professionals have access to important research. Springer Established in 1842, Springer is a leading global scientific, technical, medical, humanities and social sciences publisher. Providing researchers with quality content via innovattive products and services, Springer has one of the most significant science eBooks and archives collections, as well as a comprehensive range of hybrid and open access journals. Nature Research Publishing some of the most significant discoveries since 1869. Nature Research publishes the world’s leading weekly science journal, Nature, in addition to Nature- branded research and review subscription journals. The portfolio also includes Nature Communications, the leading open access journal across all sciences, plus a variety of Nature Partner Journals, developed with institutions and societies. Academic journals on nature.com Prestigious titles in the clinical, life and physical sciences for communities and established medical and scientific societies, many of which are published in partnership a society. Adis A leading international publisher of drug-focused content and solutions. Adis supports work in the pharmaceutical and biotech industry, medical research, practice and teaching, drug regulation and reimbursement as well as related finance and consulting markets. Apress A technical publisher of high-quality, practical content including over 3000 titles for IT professionals, software developers, programmers and business leaders around the world.
    [Show full text]
  • NLM Board of Regents Public Service Working Group on Clinicaltrials.Gov Modernization
    NLM Board of Regents Public Service Working Group on ClinicalTrials.gov Modernization Chair: Carlos R. Jaén, MD, PhD, University of Texas Health Science Center at San Antonio Executive Secretary: Rebecca (Becky) J. Williams, PharmD, MPH, National Library of Medicine, NIH Board of Regents Members: • Lourdes Baezconde-Garbanati, PhD, MPH, University of Southern California • Kent J. DeZee, MD, MPH, FACP, COL, MC, U.S. Army Office of the Surgeon General • Gary A. Puckrein, PhD, National Minority Quality Forum Ex Officio Members: • Lyric A. Jorgenson, PhD, Office of Science Policy, NIH • Pamela Reed Kearney, MD, Office of Extramural Research, NIH External Members: • Carrie Dykes, PhD, University of Rochester Medical Center • Alissa Gentile, MSN, RN, The Leukemia and Lymphoma Society • Sally A. Gore, MS, MS LIS, University of Massachusetts Medical School • Barbara Kress, BSN, RN, Merck • Seth A. Morgan, MD, National Multiple Sclerosis Society • Stephen J. Rosenfeld, MD, MBA, SACHRP • Joseph S. Ross, MD, MHS, Yale School of Medicine • Steven Woloshin, MD, The Dartmouth Institute Page 1 of 7 Biographies CHAIR: CARLOS R. JAÉN Carlos R. Jaén, MD, PhD, is the Holly Distinguished Chair, Patient-Centered Medical Home, Professor and Chair of Family and Community Medicine, and Professor of Population Health at the University of Texas Health Science Center at San Antonio. Dr. Jaén’s research interests focus on improving preventive care for individuals of all ages and preventing complications from chronic diseases such as diabetes, high blood pressure, and heart disease. He is passionate about building and studying high-performance primary care offices. He served on the panels that published smoking cessation guidelines in 1996 and 2000 and was co-chair of the panel that published an update in 2008.
    [Show full text]
  • Open-Access News Around The
    Unbound compiled by Elizabeth L Fleischer Global Initiative on Sharing Avian is developing its own e-print repository, Open-Access Influenza Data Launched which as of this writing was expected to In August 2006, Peter Bogner, Ilaria Capua, go live toward the end of 2006 and be News Around Nancy Cox, and David Lipman launched available at www.nerc.ac.uk/about/access/ the Global Initiative on Sharing Avian repository.asp. Two of the NERC collabora- the Net Influenza Data (GISAID), a project to tive centers—Plymouth Marine Laboratory provide open access to H5N1 avian influ- and the National Oceanography Centre, enza data. They published an open letter in Southhampton—already have repositories Nature calling on all influenza scientists to available. participate in it. A 24 August press release See www.nerc.ac.uk/about/access and from GISAID announced that the forma- Peter Suber, SPARC Open Access tion of the consortium of leading medical Newsletter, issue 101, 2 September 2006, researchers around the world is “designed to www.earlham.edu/~peters/fos/newsletter/ improve the sharing of influenza data, ana- 09-02-06.htm. lyze data findings jointly, and publish the results collaboratively as part of the Global Open Access Central Expands Initiative on Sharing Avian Influenza from BioMed to Chemistry and Data (GISAID)”. Data collected under Beyond the initiative will be deposited in three The team that created BioMed Central, major publicly available databases: EBML the world’s largest biomedical open-access (United Kingdom), DDBJ (Japan), and publisher, is now moving into chemistry GenBank (United States). The GISAID and has plans to expand into physics and consortium is open to all scientists, “pro- mathematics, calling the expanded pub- vided they agree to share their own data, lishing collection Open Access Central.
    [Show full text]
  • Contents Commentaries Original Articles
    Contents Volume 63 Issue 5 | GUT May 2014 Commentaries 753 Characterisation of faecal protease activity 705 Oesophageal mucosal barrier: a key factor in the in irritable bowel syndrome with diarrhoea: pathophysiology of non-erosive refl ux disease OPEN ACCESS origin and effect of gut transit (NERD) and a potential target for treatment D Tooth, K Garsed, G Singh, L Marciani, C Lam, P Woodland, D Sifrim I Fordham, A Fields, R Banwait, M Lingaya, R Layfi eld, M Hastings, P Whorwell, R Spiller Gut: first published as on 1 May 2014. Downloaded from Caption: Night view of the beautiful skyline of Chicago downtown. The Gut family wish everyone 706 The antidiabetic gutsy role of metformin a very successful DDW meeting in Chicago. uncovered? Infl ammatory bowel disease R Burcelin 761 Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks An international journal of 707 Fbxw7 hotspot mutations and human OPEN ACCESS are increased in infl ammatory bowel disease gastroenterology and hepatology colon cancer: mechanistic insights and colon cancer Impact Factor: 10.732 M Prorok-Hamon, M K Friswell, A Alswied, Editor from new mouse models C L Roberts, F Song, P K Flanagan, P Knight, Emad El-Omar (UK) J E Grim Deputy Editor (Hepatology) C Codling, J R Marchesi, C Winstanley, N Hall, Alexander Gerbes (Germany) J M Rhodes, B J Campbell Deputy Editor (Luminal 709 Editing liver tumours Gastroenterology) S Colnot, P Fortes William Grady (USA) 771 Mortality and causes of death in Crohn’s disease: results from 20 years of follow-up
    [Show full text]